Aphria, Tilray Granted Regulatory Clearance Under Competition Act For Combination
Aphria Inc (TSX: APHA) (NASDAQ: APHA) this evening reported that the transaction with that of Tilray Inc (NASDAQ: TLRY) is
Read more
Tilray
Tilray Selected To Supply Medical Cannabis For French Experimental Program
Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company this morning revealed that it
Read more
Village Farms: Raymond James Speculates On Acquisition By Canopy Growth
This morning, Raymond James sent out a note to investors giving a scenario analysis where Canopy Growth (TSX: WEED) (NASDAQ:
Read more
Tilray & Aphria: The Analyst Perspective
This morning it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray Inc (NASDAQ: TLRY) would be combining
Read more
Aphria, Tilray Announce $5 Billion Merger Justified By Topline Revenues
Well it appears the rumours have finally come to fruition when it comes to Aphria Inc (TSX: APHA) (NASDAQ: APHA)
Read more
Tilray Exchanges $72.9 Million In Convertible Notes For Shares At 42% Discount
Tilray Inc (NASDAQ: TLRY) has entered into an agreement to exchange $72.9 million worth of its convertible notes to that
Read more
Tilray: Ladenburg Thalmann Remains Neutral Following Q3 Results
Monday night Tilray Inc (NASDAQ: TLRY) reported its third quarter results. Revenue for the quarter was $51.4 million, flat quarter
Read more
Palantir: The Future Of Organizational Data Science Because It Says So
Three weeks past its September 29, 2020 IPO, controversial data-science enterprise software company Palantir Technologies (NYSE: PLTR) is settling in
Read more
FOUR20 Acquires Funding For Litigation Against Tilray
It seems that previously reported litigation against Tilray Inc (NASDAQ: TLRY) will be proceeding following an extended period of time.
Read more
Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick
Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending September 19th. In the summary,
Read more